| Name | Title | Contact Details |
|---|
Eastern Maine Healthcare Systems (EMHS) is committed to delivering quality and cost-effective patient care despite the difficult healthcare environment that's challenging the nation and the residents of Maine.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Metropolitan Health Networks, Inc. is a West Palm Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Visit us at www.drugs.com.
Rodeo Dental & Orthodontics is transforming the world of dentistry into a bright, fun-filled, high-end experience. How? By combining beautiful smiles, world-class service, and magical patient engagement techniques into memorable experiences that are shared instantly with family and friends!